Polymyxin B-immobilised haemoperfusion and mortality in critically ill patients with sepsis/septic shock: a protocol for a systematic review and meta-analysis

INTRODUCTION: Polymyxin-B immobilised haemoperfusion (PMX-HP) is a promising adjuvant strategy for the treatment of sepsis and septic shock. PMX-HP therapy works by clearing circulating endotoxin through binding to polymyxin-immobilised fibres during haemoperfusion. Small clinical trials have shown...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujii, Tomoko, Ganeko, Riki, Kataoka, Yuki, Featherstone, Robin, Bagshaw, Sean M, Furukawa, Toshi A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Intensive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5128836/
https://www.ncbi.nlm.nih.gov/pubmed/27872122
http://dx.doi.org/10.1136/bmjopen-2016-012908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5128836/
https://www.ncbi.nlm.nih.gov/pubmed/27872122
http://dx.doi.org/10.1136/bmjopen-2016-012908

Ejemplares similares